Burgess Paul D. 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jul 6, 2023
Insider Transaction Report
Form 4
Burgess Paul D.
See Remarks
Transactions
- Award
Restricted Stock Units
2023-07-03+23,847→ 23,847 total→ Common Stock (23,847 underlying) - Award
Stock Option (Right to Buy)
2023-07-03+95,931→ 95,931 totalExercise: $31.45Exp: 2033-07-03→ Common Stock (95,931 underlying)
Footnotes (2)
- [F1]25% of this option shall vest and become exercisable on July 3, 2024, with the remainder vesting in thirty-six (36) monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- [F2]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of July 3, 2024, July 3, 2025, July 3, 2026 and July 3, 2027, subject to the Reporting Person's continued service on each such vesting date.